Advances in Glaucoma Diagnosis and Therapy for the Next Millennium: New Drugs for Trabecular and Uveoscleral Outflow

References

• Gabelt B T, Kaufman P L. Normal physiology. Uveosclerat Outflow: Biology and Clinical Aspects, A Alm, R N Weinreb. Mosby-Wolfe Medical Communications, London 1998; 25–39
   Google Scholar
• Toris C B, Yablonski M E, Camras C B, et al. Uveoscleral outflow decreases with age in ocular normotensive humans. Invest Ophthalmol Vis Sci 1996; 37: S410, ARVO Abstracts
   Web of Science ®Google Scholar
• Polansky J R, Bloom E, Konami D, et al. Cultured human trabecular cells: Evaluation of hormonal and pharmacological responses in vitro. Recent Advances in Glaucoma, U Ticho, U Ticho. Excerpta Medica, Amsterdam 1984; 201–206
   Google Scholar
• Perkins T W, Alvarado J A, Polansky J R, et al. Trabecular meshwork cells grown on filters: Conductivity and cytochalasin effects. Invest Ophthalmol Vis Sci 1988; 29: 1836–1846
   PubMed Web of Science ®Google Scholar
• Gills J P, Roberts B C, Epstein D L. Microtubule disruption leads to cellular contraction in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 1998; 39: 653–658
   PubMed Web of Science ®Google Scholar
• Liu X, Glasser A, Croft M A, et al. Effect of H-7 on cultured human trabecular meshwork (HTM) cells. Invest Ophthalmol Vis Sci 1998; 39: S705, ARVO Abstracts
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Bárány E H. Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey. Invest. Ophthalmol. Vis. Sci 1977; 16: 47–53
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Bill A, Bárány E H. Effect of cytochalasin B on conventional drainage of aqueous humor in the cynomolgus monkey. Exp Eye Res 1977; 25(Suppl)411–414
   PubMedGoogle Scholar
• Kaufman P L, Erickson K A. Cytochalasin B and D dose-outflow facility response relationships in the cynomolgus monkey. Invest Ophthalmol Vis Sci 1982; 23: 646–650
   PubMed Web of Science ®Google Scholar
• Kaufman P L. Non-additivity of maximal pilocarpine and cytochalasin effects on outflow facility. Exp Eye Res 1987; 44: 283–291
   PubMed Web of Science ®Google Scholar
• Svedbergh B, Lütjen-Drecoll E, Ober M, et al. Cytochalasin B-induced structural changes in the anterior ocular segment of the cynomolgus monkey. Invest Ophthalmol Vis Sci 1978; 17: 718–734
   PubMed Web of Science ®Google Scholar
• Johnstone M, Tanner D, Chau B, et al. Concentration-dependent morphologic effects of cytochalasin B in the aqueous outflow system. Invest Ophthalmol Vis Sci 1980; 19: 835–841
   PubMed Web of Science ®Google Scholar
• Tian B, Kaufman P L, Volberg T, et al. H-7 disrupts the actin cytoskeleton and increases outflow facility. Arch Ophthalmol 1998; 116: 633–643
   PubMed Web of Science ®Google Scholar
• Peterson J A, Tian B, Bershadsky A D, et al. Latrunculin-A increases outflow facility in the monkey. Invest Ophthalmol Vis Sci 1999; 40: 931–941
   PubMed Web of Science ®Google Scholar
• Bill A, Lutjen-Drecoll E, Svedbergh B. Effects of intra-cameral Na2EDTA and EGTA on aqueous outflow routes in the monkey eye. Invest Ophthalmol Vis Sci 1980; 19: 492–504
   PubMed Web of Science ®Google Scholar
• Brenner S L, Korn E D. Substoichiometric concentrations of cytochalasin D inhibit actin polymerization: Additional evidence for an F-actin treadmill. J Biol Chem 1979; 254: 9982–9985
   PubMed Web of Science ®Google Scholar
• Brown S S, Spudich J A. Mechanism of action and cytochalasin: Evidence that it binds to actin filament ends. J Cell Biol 1981; 88: 487–491
   PubMed Web of Science ®Google Scholar
• Davies P, Allison A C. Effects of cytochalasin B on endocytosis and exocytosis. Cytochalasins: Biochemical and Cell Biological Aspects, S W Tannenbaum. North Holland, Amsterdam 1978; 143–160
   Google Scholar
• Godman G C, Miranda A F. Cellular contractility and the visible effects of cytochalasin. Cytochalasins: Biochemical and Celt Biological Aspects, S W Tannenbaum. North Holland, Amsterdam 1978; 277–429
   Google Scholar
• Cooper J A. Effects of cytochalasins and phalloidin on actin. J Cell Biol 1987; 105: 1473–1478
   PubMed Web of Science ®Google Scholar
• Kolega J, Janson L W, Taylor D L. The role of solation-contraction coupling in regulating stress fiber dynamics in non-muscle cells. J Cell Biol 1991; 114: 993–1003
   PubMed Web of Science ®Google Scholar
• Coué M, Brenner S L, Spector I, et al. Inhibition of actin polymerization by latrunculin A. FEBS Lett 1987; 213: 316–318
   PubMed Web of Science ®Google Scholar
• Spector I, Shochet N R, Blasberger D, et al. Latrunculins-novel marine macrolides that disrupt microfilament organization and affect cell growth: Comparison with cytochalasin D. Cell Motil Cytoskel 1989; 13: 27–144
   Web of Science ®Google Scholar
• Volberg T, Geiger B, Citi S, et al. Effect of protein kinase inhibitor H-7 on the contractility, integrity, and membrane anchorage of the microfilament system. Cell Motility Cytoskel 1994; 29: 321–338
   PubMed Web of Science ®Google Scholar
• Citi S, Volberg T AD, Bershadsky A, et al. Cytoskeletal involvement in the modulation of cell-cell junctions by the protein kinase inhibitor H-7. J Cell Sci 1994; 107: 683–692
   PubMedGoogle Scholar
• Tian B, Millar C, Kaufman P L, et al. Effects of H-7 on the iris and ciliary muscle in monkeys. Arch Ophthalmol 1998; 116: 1070–1077
   PubMedGoogle Scholar
• Mobley P L, Hedberg K, Bonin L, et al. Decreased phos-phorylation of four 20-kDa proteins precedes staurosporine-induced disruption of the actin/myosin cytoskeleton in rat astrocytes. Exp Cell Res 1994; 214: 55–66
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Seto M, Komatsu K, et al. Staurosporine, a protein kinase inhibitor, attenuates intracellular Ca(2+)-depen-dent contractions of strips of rabbit aorta. Eur J Pharmacol 1991; 202: 367–372
   PubMed Web of Science ®Google Scholar
• Wiederholt M, Groth J, Strauss O. Role of protein tyrosine kinase on regulation of trabecular meshwork and cilary muscle contractility. Invest Ophthalmol Vis Sci 1998; 39: 1012–1020
   PubMed Web of Science ®Google Scholar
• Farooki A Z, Epstein D L, O'Brien E T. Tyrphostins disrupt stress fibers and cellular attachments in endothelial monolayers. Exp Cell Res 1998; 243: 185–198
   PubMed Web of Science ®Google Scholar
• Gabelt B T, Tian B, Volberg T, et al. Outflow facility effects in monkeys following intracameral (1) H-7 + cytochalasin B; (2) tyrphostins. Invest Ophthalmol Vis Sci 1998; 39: S483, ARVO Abstracts
   Google Scholar
• Sung C P, Arleth A J, Storer B, et al. Modulation of U937 cell adhesion to vascular endothelial cells by cyclic AMP. Life Sci 1991; 49: 375–382
   PubMed Web of Science ®Google Scholar
• Tripathi B J, Tripathi R C, Millard C B. Epinephrineinduced toxicity of human trabecular cells in vitro. Lens & Eye Tox Res 1989; 6: 141–156
   PubMedGoogle Scholar
• Petty H R, Martin S M. Combinative ligand-receptor interactions: Effects of cAMP, epinephrine, and met-enkephalin on RAW264 macrophage morphology, spreading, adherence, and microfilaments. J Cell Physiol 1989; 138: 247–256
   PubMed Web of Science ®Google Scholar
• Shattil S J, Haimovich B, Cunningham M, et al. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signalling through integrin and agonist receptors. J Biol Chem 1994; 269: 14738–14745
   PubMed Web of Science ®Google Scholar
• Benschop R J, Oostveen F G, Heijnin C J, et al. β2-Adrener-gic stimulation causes detachment of natural killer cells from cultured endothelium. Eur J Immunol 1993; 23: 3242–3247
   PubMed Web of Science ®Google Scholar
• Kawa J E, Higginbotham E J, Chang I L, et al. Effects of antiglaucoma medications on bovine trabecular meshwork cells in vitro. Exp Eye Res 1993; 57: 557–565
   PubMed Web of Science ®Google Scholar
• Tripathi B J, Tripathi R C. Effect of epinephrine in vitro on the morphology, phagocytosis, and mitotic activity of human trabecular endothelium. Exp Eye Res 1984; 39: 731–744
   PubMed Web of Science ®Google Scholar
• Alvarado J A. Epinephrine effects on major cell types of the aqueous outflow pathways: In vitro studies/clinical implications. Tr Am Ophth Soc 1990; 88: 267–288
   PubMedGoogle Scholar
• Robinson J C, Kaufman P L. Cytochalasin B potentiates epinephrine's outflow facility increasing effect. Invest Ophthalmol Vis Sci 1991; 32: 1614–1618
   PubMed Web of Science ®Google Scholar
• Robinson J C, Kaufman P L. Phalloidin inhibits epinephrine's and cytochalsin B's facilitation of aqueous outflow. Arch Ophthalmol 1994; 112: 1610–1613
   PubMedGoogle Scholar
• Croft M A, Kaufman P L. Effect of daily topical ethacrynic acid on aqueous humor dynamics in monkeys. Curr Eye Res 1995; 14: 777–781
   PubMed Web of Science ®Google Scholar
• Croft M A, Hubbard W C, Kaufman P L. Effect of ethacrynic acid on aqueous outflow dynamics in monkeys. Invest Ophthalmol Vis Sci 1994; 35: 1167–1175
   PubMed Web of Science ®Google Scholar
• Epstein D L, Freddo T F, Bassett-Chu S, et al. Influence of ethacrynic acid on outflow facility in the monkey and calf eye. Invest Ophthalmol Vis Sci 1987; 28: 2067–2075
   PubMed Web of Science ®Google Scholar
• Johnson D H, Tschumper R C. Ethacrynic acid: Outflow effects and toxicity in human trabecular meshwork in perfusion organ culture. Curr Eye Res 1993; 12: 385–396
   PubMed Web of Science ®Google Scholar
• Liang L L, Epstein D L, de Kater A W, et al. Ethacrynic acid increases facility of outflow in the human eye in vitro. Arch Ophthalmol 1992; 110: 106–109
   PubMedGoogle Scholar
• Matthews J B, Awtrey C S, Madara J L. Microfilament-dependent activation of Na/K/2C1 cotransport by cAMP in intestinal epithelial monolayers. J Clin Invest 1992; 90: 1608–1613
   PubMed Web of Science ®Google Scholar
• Jessen F, Hoffmann E K. Activation of the Na/K/Cl cotransport system by reorganization of the actin filaments in Ehrlich ascites tumor cells. Biochim Biophys Acta 1992; 1110: 199–201
   PubMedGoogle Scholar
• O'Donnell M E. Role of Na-K-Cl cotransport in vascular endothelial cell volume regulation. Am J Physiol 1993; 264: C1316–C1326
   Google Scholar
• O' Donnell M E, Brandt J D, Curry F RE. Na-K-Cl cotransport regulates intracellular volume and monolayer permeability of trabecular meshwork cells. Am J Physiol 1995; 268: C1067–C1074
   Google Scholar
• Putney L K, Brandt J D, O'Donnell M E. Effects of dexa-methasone on sodium-potassium-chloride cotransport in trabecular meshwork cells. Invest Ophthalmol Vis Sci 1997; 38: 1229–1240
   PubMed Web of Science ®Google Scholar
• Gabelt B T, Wiederholt M, Clark A F, et al. Anterior segment physiology following bumetanide inhibition of Na-K-Cl cotransport. Invest Ophthalmol Vis Sci 1997; 38: 1700–1707
   PubMed Web of Science ®Google Scholar
• Wiederholt M, Dörschner N, Groth J. Effect of diuretics, channel modulators, and signal interceptors on contractility of the trabecular meshwork. Ophthalmologica 1997; 211: 153–160
   PubMed Web of Science ®Google Scholar
• Putney L K, Brandt J D, O'Donnell M E. Na-K-Cl cotransport in normal and glaucomatous human trabecular meshwork cells. Invest Ophthalmol Vis Sci 1999; 40: 425–434
   PubMedGoogle Scholar
• Kaufman P L. Pharmacologic trabeculocanalotomy. Facilitating aqueous outflow by assaulting the meshwork cytoskeleton, junctional complexes, and extracellular matrix. Arch Ophthalmol 1992; 110: 34–36
   PubMedGoogle Scholar
• Epstein D L. Open angle glaucoma. Why not a cure? [editorial]. Arch Ophthalmol 1987; 105: 1187–1188
   PubMedGoogle Scholar
• Inomata H, Bill A, Smelser G K. Aqueous humor pathways through the trabecular meshwork and into Schlemm's canal in the cynomolgus monkey (Macaca irus). Am J Ophthalmol 1972; 73: 760–789
   PubMed Web of Science ®Google Scholar
• Bill A, Svedbergh B. Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm: An attempt to localize the main resistance to outflow of aqueous humor in man. Acta Ophthalmol 1972; 50: 295–320
   PubMed Web of Science ®Google Scholar
• Bill A. Blood circulation and fluid dynamics in the eye. Physiol Rev 1975; 55: 383–417
   PubMed Web of Science ®Google Scholar
• Bárány E H, Scotchbrook S. Influence of testicular hyal-uronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand 1954; 30: 240–248
   PubMedGoogle Scholar
• Pedler W S. The relationship of hyaluronidase to aqueous outflow resistance. Trans Ophthalmol Soc UK 1956; 76: 51–63
   PubMedGoogle Scholar
• Grant W M. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol 1963; 69: 783–801
   PubMed Web of Science ®Google Scholar
• Peterson W S, Jocson V L. Hyaluronidase effects on aqueous outflow resistance: Quantitative and localizing studies in the rhesus monkey eye. Am J Ophthalmol 1974; 77: 573–577
   PubMed Web of Science ®Google Scholar
• Hubbard W C, Johnson M, Gong H, et al. Intraocular pressure and outflow facility are unchanged following acute and chronic intracameral chondroitinase ABC and hyaluronidase in monkeys. Exp Eye Res 1997; 65: 177–190
   PubMed Web of Science ®Google Scholar
• Bill A. Effects of Na2EDTA and alpha-chymotrypsin on aqueous humor outflow conductance in monkey eyes. Uppsala J Med Sci 1980; 85: 311–319
   PubMed Web of Science ®Google Scholar
• Sawaguchi S, Yue B Y, Yeh P, et al. Effects of intracameral injection of chondroitinase ABC in vivo. Arch Ophthalmol 1992; 110: 110–117
   PubMedGoogle Scholar
• Hanamaka T, Bill A. Effect of α-chymotrypsin on the outflow routes for aqueous humor. Exp Eye Res 1988; 46: 323–341
   PubMed Web of Science ®Google Scholar
• Cousins S W, McCabe M M, Danielpour D, et al. Identification of transforming growth factor-beta as an immunosuppres-sive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991; 32: 2201–2211
   PubMed Web of Science ®Google Scholar
• Streilein J W, Bradley D. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest Ophthalmol Vis Sci 1991; 32: 2700–2710
   PubMed Web of Science ®Google Scholar
• Streilein J W, Wilbanks G A, Cousins S W. Immunoregula-tory mechanisms of the eye. J Neuroimmunol 1992; 39: 185–200
   PubMedGoogle Scholar
• Streilein J W, Wilbanks G A, Taylor A, et al. Eye-derived cytokines and the immunosuppressive intraocularmicroenviron-ment: A review. Curr Eye Res 1992; ll(Suppl)41–47
   Google Scholar
• Tripathi R C, Borisuth N S, Kolli S P, et al. Trabecular cells express receptors that bind TGF-beta 1 and TGF-beta 2: A qualitative and quantitative characterization. Invest Ophthalmol Vis Sci 1993; 34: 260–263
   PubMed Web of Science ®Google Scholar
• Borisuth N S, Tripathi B J, Tripathi R C. Identification and partial characterization of TGF-beta 1 receptors on trabecular cells. Invest Ophthalmol Vis Sci 1992; 33: 596–603
   PubMed Web of Science ®Google Scholar
• Tripathi R C, Li J, Borisuth N S, et al. Trabecular cells of the eye express messenger RNA for transforming growth factor-beta 1 and secrete this cytokine. Invest Ophthalmol Vis Sci 1993; 34: 2562–2569
   PubMed Web of Science ®Google Scholar
• Tripathi R C, Chan W F, Li J, et al. Trabecular cells express the TGF-beta 2 gene and secrete the cytokine. Exp Eye Res 1994; 58: 523–528
   PubMed Web of Science ®Google Scholar
• Lütjen-Drecoll E, Liebe S, Prehm P. HA-receptors and regulation of HA-synthesis in the primate trabecular meshwork. Invest Ophthalmol Vis Sci 1995; 36: S725, ARVO Abstracts
   Web of Science ®Google Scholar
• Siegner A, Lütjen-Drecoll E. Transforming growth factor-βI stimulates human trabecular meshwork cells to produce increased amounts of collagen type VI mRNA. Invest Ophthalmol Vis Sci 1995; 36: S727, ARVO Abstract
   Web of Science ®Google Scholar
• Alexander J P, Samples J R, Acott T S. Growth factor and cytokine modulation of trabecular meshwork matrix metallopro-teinase and TIMP expression. Curr Eye Res 1998; 17: 276–285
   PubMed Web of Science ®Google Scholar
• Seong G J, Kay E P, Minckler D S. Regulation of the levels of trabecular matrix metalloproteinases by transforming growth factor β1. Invest Ophthalmol Vis Sci 1995; 36: S727, ARVO Ab-stracts
   Web of Science ®Google Scholar
• Clark A F. New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest Ophthalmol Vis Sci 1998; 39: 2514–2516
   PubMed Web of Science ®Google Scholar
• Alexander J P, Samples J R, Van Buskirk E M, Acott T S. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991; 32: 172–180
   PubMed Web of Science ®Google Scholar
• Samples J R, Alexander J R, Acott T S. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interieukin-1 and dexamethasone. Invest Ophthalmol Vis Sci 1993; 34: 3386–3395
   PubMed Web of Science ®Google Scholar
• Bradley J MB, Vranka J, Colvis C M, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998; 39: 2649–2658
   PubMed Web of Science ®Google Scholar
• Parshiey D E, Bradley J M, Samples J R, et al. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res 1995; 14: 537–544
   PubMed Web of Science ®Google Scholar
• Parshiey D E, Bradley J M, Fisk A, et al. Laser trabecu-loplasty induces stromelysin expression by trabecular juxtaca-nalicular cells. Invest Ophthalmol Vis Sci 1996; 37: 795–804
   PubMed Web of Science ®Google Scholar
• Lütjen-Drecoll E, Rohen J W. Morphology of aqueous outflow pathways in normal and glaucomatous eyes. The Glaucomas, R Ritch, M B Shields, T Krupin. Mosby, St. Louis, MO 1996; 89–123
   Google Scholar
• Hernandez M R, Gong H. Extracellular matrix of the trabecular meshwork and optic nerve head. The Glaucomas, Basic Sciences, 2nd edition, R Ritch, M B Shields, T Krupin. Mosby, St. Louis, MO 1996; 213–249
   Google Scholar
• Geiger B, Tokuyasu K T, Dutton A H, et al. Vinculin, an intracellular protein localized at specialized sites where microfil-ament bundles terminate at cell membranes. Proc Natl Acad Sci USA 1980; 77: 4127–4131
   PubMed Web of Science ®Google Scholar
• Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8: 1711–1717
   PubMed Web of Science ®Google Scholar
• Geiger B, Yehuda-Levenberg S, Bershadsky A D. Molecular interactions in the submembrane plaque of cell-cell and cell-matrix adhesions. Acta Anal 1995; 154: 46–62
   Google Scholar
• Yamada K M, Geiger B. Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol 1997; 9: 75–85
   Web of Science ®Google Scholar
• Ben-Ze'ev A, Rodriguez Fernandez J L, Gluck U, et al. Changes in adhesion plaque protein levels regulate cell motility and tumorigenicity. Adv Exp Med Biol 1994; 358: 147–157
   PubMedGoogle Scholar
• Sampath P, Pollard T D. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochem 1991; 30: 1973–1980
   PubMed Web of Science ®Google Scholar
• Birrell G B, Hedberg K K, Habliston D L, et al. Protein kinase C inhibitor H-7 alters the actin cytoskeleton of cultured cells. J Cell Physiol 1989; 141: 74–84
   PubMed Web of Science ®Google Scholar
• Tian B, Gabelt B T, Kaufman P L. Effect of staurosporine on outflow facility in monkeys. Invest Ophthalmol Vis Sci 1999; 40: 1009–1011
   PubMed Web of Science ®Google Scholar
• Tian B, Gabelt B T, Peterson J A, et al. H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys. Invest Ophthalmol Vis Sci 1999; 40: 239–242
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Peterson J A, Tian B, et al. An actin drug for glaucoma. Exp Eye Res 1998; 67(Suppl 1)S53, XIII ICER Ab-stracts
   PubMedGoogle Scholar
• Gabelt B T, Sabanai I, Tian B, et al. Effect of the protein kinase inhibitor H-7 on the structure and fluid conductance of the trabecular meshwork of live monkeys. Invest Ophthalmol Vis Sci 1999; 40: S667, ARVO Abstracts
   Web of Science ®Google Scholar
• Gabelt B T, Kaufman P L. Pharmacologic enhancement of aqueous humor outflow. 100 Years of Progress in Glaucoma, E M Van Buskirk, M B Shields. Lippin-cott, Philadelphia, PA 1997; 237–261
   Google Scholar
• Rohen J W, Lütjen E, Bárány E. The relation between the ciliary muscle and the trabecular meshwork and its importance for the effect of miotics on aqueous outflow resistance. Graefes Arch Clin Exp Ophthalmol 1967; 172: 23–47
   Google Scholar
• Kaufman P L. Total iridectomy does not alter outflow facility responses to cyclic AMP in cynomolgus monkeys. Exp Eye Res 1986; 43: 441–447
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Bárány E H. Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey. Invest Ophthalmol 1976; 15: 793–807
   PubMedGoogle Scholar
• Kaufman P L, Gabelt B T. Direct, indirect and dual action parasympathetic drugs. Textbook of Ocular Pharmacology, T J Zimmerman. Lippincott, Philadelphia, PA 1997; 221–238
   Google Scholar
• Gupta N, Drance S M, McAllister R, et al. Localization of M3 muscarinic receptor subtype and mRNA in the human eye. Ophthalmic Res 1994; 26: 207–213
   PubMed Web of Science ®Google Scholar
• Gupta N, McAllister R, Drance S M, et al. Muscarinic receptor Ml and M2 subtypes in the human eye: QNB, pirenzip-ine. oxotremorine, and AFDX-116 in vitro autoradiography. Br J Ophthalmol 1994; 78: 555–559
   PubMed Web of Science ®Google Scholar
• Zhang X, Hernandez M R, Yang H, et al. Expression of muscarinic receptor subtype mRNA in the human ciliary muscle. Invest Ophthalmol Vis Sci 1995; 36: 1645–1657
   PubMed Web of Science ®Google Scholar
• Ishikawa H, DeSantis L, Patil P N. Selectivity of muscarinic agonists including (±)-aceclidine and antimuscarinics on the human intraocular muscles. J Ocular Pharmacol Ther 1998; 14: 363–373
   PubMed Web of Science ®Google Scholar
• Gil D W, Krauss H A, Bogardus A M, et al. Muscarinic receptor subtypes in human iris-ciliary body measured by immu-noprecipitation. Invest Ophthalmol Vis Sci 1997; 38: 1434–1442
   PubMed Web of Science ®Google Scholar
• WoldeMussie E, Feldmann B, Chen J. Characterization of muscarinic receptors in cultured human iris sphincter and ciliary smooth muscle cells. Exp Eye Res. 1993; 56: 385–392
   PubMed Web of Science ®Google Scholar
• Wiederholt M, Schafer R, Wagner U, et al. Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents. German J Ophthalmol 1996; 5: 146–153
   PubMedGoogle Scholar
• Flügel C, Bárány E H, Lütjen-Drecoll E. Histochemical differences within the ciliary muscle and its function in accommodation. Exp Eye Res 1990; 50: 219–226
   PubMed Web of Science ®Google Scholar
• Erickson-Lamy K A, Kaufman P L. Effect of cholinergic drugs on outflow facility after ciliary ganglionectomy. Invest Ophthalmol Vis Sci 1988; 29: 491–494
   PubMed Web of Science ®Google Scholar
• Erickson-Lamy K A, Kaufman P L, Polansky J R. Dissociation of cholinergic supersensitvity from receptor number in ciliary muscle. Invest Ophthalmol Vis Sci 1988; 29: 600–605
   PubMed Web of Science ®Google Scholar
• Erickson-Lamy K A, Kaufman P L. Reinnervation of primate ciliary muscle following ciliary ganglionectomy. Invest Ophthalmol Vis Sci 1987; 28: 927–933
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Erickson-Lamy K A, Rohen J W, et al. The ciliary muscle and nerves after ciliary ganglionectomy. Glaucoma Update IV. Proceedings of the Symposium of the Glaucoma Society of the International Congress of Ophthalmology in Bali, G K Krieglstein. Springer-Verlag, Berlin 1991; 36–51
   Google Scholar
• Bárány E H. Dissociation of accommodation effects from outflow effects of pilocarpine. Drug Mechanisms in Glaucoma, G Paterson, S JH Miller, G H Pater-Son. Churchill Ltd, London 1966; 275–282
   Google Scholar
• Croft M A, Oyen M J, Gange S J, et al. Aging effects on accommodation and outflow facility responses to pilocarpine in humans. Arch Ophthalmol 1996; 114: 586–592
   PubMed Web of Science ®Google Scholar
• Erickson-Lamy K, Schroeder A. Dissociation between the effect of aceclidine on outflow facility and accommodation. Exp Eye Res 1990; 50: 143–147
   PubMed Web of Science ®Google Scholar
• Gabelt B T, Kaufman P L. Inhibition of aceclidine-stimu-Iated outflow facility, accommodation, and miosis by muscarinic receptor subtype antagonists in rhesus monkeys. Exp. Eye Res 1994; 58: 623–630
   PubMed Web of Science ®Google Scholar
• Lieberman T W, Leopold I H. The use of aceclidine in the treatment of glaucoma. Its effect on intraocular pressure and facility of aqueous humor outflow as compared to that of pilocarpine. Am J Ophthalmol 1967; 64: 405–415
   PubMed Web of Science ®Google Scholar
• Romano J H. Double-blind crossover comparison of aceclidine and pilocarpine in open-angle glaucoma. Br J Ophthalmol 1970; 54: 510–521
   PubMed Web of Science ®Google Scholar
• Gabelt B T, Kaufman P L. Inhibition of outflow facility, accommodative, and miotic responses to pilocarpine in rhesus monkeys by muscarinic receptor subtype antagonists. J Pharmacol Exp Ther 1992; 263: 1133–1139
   PubMed Web of Science ®Google Scholar
• Poyer J F, Gabelt B T, Kaufman P L. The effect of muscarinic agonists and selective receptor subtype antagonists on the contractile response of the isolated rhesus monkeys ciliary muscle. Exp Eye Res 1994; 59: 729–736
   PubMed Web of Science ®Google Scholar
• Erickson-Lamy K, Korbmacher C, Schuman J S, et al. Effect of endothelin on outflow facility and accommodation in the monkey eye in vivo. Invest Ophthalmol Vis Sci 1991; 32: 492–495
   PubMed Web of Science ®Google Scholar
• Millar J C, Gabelt B T, Hubbard W C, et al. Endothelin-1 effects on aqueous humor dynamics in monkeys. Acta Opthalmol 1998; 76: 663–667
   Web of Science ®Google Scholar
• Millar C, Poyer J F, Gabelt B T, et al. Endothelin subtypes: Effect on isolated rhesus monkey ciliary muscle. J Pharmacol Exp Ther 1995; 275: 1143–1147
   PubMed Web of Science ®Google Scholar
• Nardin G F, Zimmerman T J. Ocular cholinergic agents. The Glaucomas, R Ritch, M B Shields, T Krupin. Mosby, St. Louis, MO 1996; 1399–1407
   Google Scholar
• Anthony T L, Pierce K L, Stamer W D, et al. Prostaglandin F2α receptors in the human trabecular meshwork. Invest Ophthalmol Vis Sci 1998; 39: 315–321
   PubMed Web of Science ®Google Scholar
• Woodward D F, Regan J W, Lake S, et al. The molecular biology and ocular distribution of prostanoid receptors. Surv Ophthalmol 1997; 41(Suppl 2)S15–S21
   PubMedGoogle Scholar
• Toris C B, Camras C B, Yablonski M E, et al. Effects of exogenous prostaglandins on aqueous humor dynamics and blood aqueous barrier function. Surv Ophthalmol 1997; 41(Suppl 2)S69–S75
   PubMed Web of Science ®Google Scholar
• Dijkstra B G, Ruijter J M, Hoyng P F. Evaluation of realtime flow measurements of effects of PGE1 and PGF2α in the organ culture anterior segment perfusion model in human eyes. Invest Ophthalmol Vis Sci 1995; 36: S137, ARVO Abstracts
   Web of Science ®Google Scholar
• Sarfarazi F, Schroeder A, Zhang X, et al. Influence of PGE2 on outflow facility in the human eye. Invest Ophthalmol Vis Sci 1994; 35: S2053, ARVO Abstracts
   Web of Science ®Google Scholar
• Wang R F, Lee P Y, Mittag T W, et al. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys. Arch Ophthalmol 1998; 116: 1213–1216
   PubMedGoogle Scholar
• Kamikawatoko S, Tokoro T, Azuma H, et al. The effects of endothelin-1 on isolated bovine ciliary muscles. Exp Eye Res 1995; 61: 559–564
   PubMed Web of Science ®Google Scholar
• Lepple-Wienhues A, Stahl F, Wunderling D, et al. Effects of endothelin and calcium channel blockers on membrane voltage and intracellular calcium in cultured bovine trabecular meshwork cells. Ger J Ophthalmol 1992; 1: 159–163
   PubMedGoogle Scholar
• Crosson C E. Ocular hypotensive activity of the adeno-sine agonist (R)-phenylisopropyladenosine in rabbits. Curr Eye Res 1992; 1l: 453–458
   Google Scholar
• Tian B, Gabelt B T, Crosson C E, et al. Effects of adeno-sine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. Exp Eye Res 1997; 64: 979–989
   PubMed Web of Science ®Google Scholar
• Crosson C E, Gray T. Adenosine agonists alter aqueous flow and outflow facility in rabbits. Invest Ophthalmol Vis Sci 1997; 38: S821, ARVO Abstracts
   Web of Science ®Google Scholar
• Crosson C E. Adenosine receptor activation modulates intraocular pressure in rabbits. J Pharmacol Exp Ther 1995; 273: 320–326
   PubMed Web of Science ®Google Scholar
• Crosson C E, Gray T. Modulation of intraocular pressure by adenosine agonists. J Ocular Pharmacol 1994; 10: 379–383
   PubMedGoogle Scholar
• Croft M A, Kiland J, Peterson J, et al. Effects of proma-zine hydrochloride on aqueous humor dynamics in monkeys. Invest Ophthalmol Vis Sci 1995; 36: S734, ARVO Abstract
   Web of Science ®Google Scholar
• Croft M A, Kaufman P L. Effect of acepromazine maleate (Promace) on aqueous humor dynamics. Invest Ophthalmol Vis Sci 1994; 35: 2051, ARVO Abstract
   Web of Science ®Google Scholar
• Hayreh S S, Kardon R H, McAllister D L, et al. Acepromazine. Effects on intraocular pressure. Arch Ophthalmol 1991; 109: 119–124
   PubMedGoogle Scholar
• Gabelt B T, Kaufman P L. Prostaglandin F2α increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989; 49: 389–402
   PubMed Web of Science ®Google Scholar
• Nilsson S FE, Samuelsson M, Bill A, et al. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2α-l-isopropylester in the cynomolgus monkey. Exp Eye Res 1989; 48: 707–716
   PubMed Web of Science ®Google Scholar
• Toris C B, Camras C B, Yablonski M E. Effects of PhXA41, a new prostaglandin F2 alpha, on aqueous humor dynamics in human eyes. Ophthalmol 1993; 100: 1297–1304
   PubMed Web of Science ®Google Scholar
• Gabelt B T, Kaufman P L. The effect of prostaglandin F2α on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res 1990; 51: 87–91
   PubMed Web of Science ®Google Scholar
• Stjernschantz J, Selen G, Sjöquist B, et al. Preclinical pharmacology of latanoprost, a phenylsubstituted PGF2a analogue. Advances in Prostaglandin, Thromboxance, and Leukotriene Research, B Samuelsson. Raven Press, New York, NY 1995; 513–518
   Google Scholar
• Poyer J F, Millar C, Kaufman P L. Prostaglandin F2α effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci 1995; 36: 2461–2465
   PubMed Web of Science ®Google Scholar
• van Alphen G WHM, Kern R, Robinette S L. Adrenergic receptors of the intraocular muscles. Comparison to cat, rabbit, and monkey. Arch Ophthalmol 1965; 74: 253–259
   PubMed Web of Science ®Google Scholar
• van Alphen G WHM, Robinette S L, Macri F J. Drug effects on ciliary muscle and choroid preparations in vitro. Arch Ophthalmol 1962; 68: 111–123
   Google Scholar
• Lindsey J D, Kashiwagi K, Kashiwagi F, et al. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism—implications for uveoscleral outflow. Surv Ophthalmol 1997; 41(Suppl 2)S53–S59
   Google Scholar
• Lütjen-Drecoll E, Tamm E. Morphological study of the anterior segments of cynomolgus monkey eyes following treatment with prostaglandin F2α. Exp Eye Res 1988; 47: 761–769
   PubMed Web of Science ®Google Scholar
• Tam E, Rittig M, Lütjen-Drecoll E. Elektronenmik-roskopische und immunhistochemische Untersuchungen zur augendrucksenkendren Wirkung von Prostaglandin F2α. Fortschr Ophthalmol 1990; 87: 623–629
   PubMedGoogle Scholar
• Sagara T, Gaton D D, Lindsey J D, et al. Prostaglandin F2α alters extracellular matrix collagens in ciliary muscle, iris root and sclera of monkey eyes in vivo. Invest Ophthalmol Vis Sci 1998; 39: S803, ARVO Abstracts
   Google Scholar
• Lindsey J D, Weinreb R N. Effects of prostaglandins on uveoscleral outflow. Uveoscleral Outflow: Biology and Clinical Aspects, A Alm, R N Weinreb. Mosby-Wolfe Medical Communications, Barcelona 1998; 41–55
   Google Scholar
• Gaton D D, Sagara T, Lindsey J D, et al. Matrix metallo-proteinases increased in vivo by prostaglandin F2α in iris root, ciliary muscle, and adjacent sclera of monkey eyes. Invest Ophthalmol Vis Sci 1998; 39: S929, ARVO Abstracts
   Google Scholar
• Sagara T, Gaton D D, Lindsey J D, et al. Collagen type I is reduced in the ciliary muscle of inflamed monkey eyes. Invest Ophthalmol Vis Sci 1998, in press
   Web of Science ®Google Scholar
• Toris C B, Pederson J E. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci 1987; 28: 477–481
   PubMed Web of Science ®Google Scholar
• Weinreb R N, Mitchell M D, Alvarado J A, et al. Glucocorticoid regulation of eicosandoid biosynthesis in cultured human trabecular cells. Recent Advances in Glaucoma, U Ticho, U Ticho. Elsevier Sciences Publishers BV, Amsterdam 1984; 213–218
   Google Scholar
• Matsumoto S, Yorio T, Magnino P E, et al. Endothelininduced changes of second messengers in cultured human ciliary muscle cells. Invest Ophthalmol Vis Sci 1996; 37: 1058–1066
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Mittag T W. Medical therapy of glaucoma. Glaucoma, P L Kaufman, T W Mittag. Mosby-Year Book Europe Ltd, London 1994; 9.7–9.30
   Google Scholar
• McGetrick J J, Wilson D G, Dortzbach R K, et al. A search for lymphatic drainage of the monkey orbit. Arch Ophthalmol 1989; 107: 255–260
   PubMedGoogle Scholar
• Camras C B, Alm A, Watson P G, et al. Latanoprost. a prostaglandin analog, for glaucoma therapy: Efficacy and safety after 1 year of treatment in 198 patients. Ophthalmol 1996; 103: 1916–1924
   PubMed Web of Science ®Google Scholar
• Azuma I, Masuda K, Kitazawa Y, et al. Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension. Jap J Ophthalmol 1993; 37: 514–525
   PubMed Web of Science ®Google Scholar
• Ziai N, Dolan J W, Kacere R D, et al. The effects of aqueous dynamics of PhXA41, a new prostaglandin F2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 1993; 111: 1351–1358
   PubMed Web of Science ®Google Scholar
• Sakuai M, Araie M, Oshika T, et al. Effects of topical application of F-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 1991; 35: 156–165
   PubMed Web of Science ®Google Scholar
• Serle J B, Podos S M, Kitazawa Y, et al. A camparative study of latanoprost (Xalatan) and isopropyl unoporostone (Rescula) in normal and glaucomatous monkey eyes. Jpn J Ophthalmol 1998; 42: 95–100
   PubMed Web of Science ®Google Scholar
• Linden C, Alm A. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes. Arch Ophthalmol 1997; 115: 857–861
   PubMed Web of Science ®Google Scholar
• Crawford K, Kaufman P L. Pilocarpine antagonizes PGF2α-induced ocular hypotension: Evidence for enhancement of uveoscleral outflow by PGF2α. Arch Ophthalmol 1987; 105: 1112–1116
   PubMed Web of Science ®Google Scholar
• Kaufman P L. Prostaglandins and cholinomimetics (editorial). Arch Ophthalmol 1997; 115: 911–913
   PubMedGoogle Scholar
• Toris C B, Gleason M L, Camras C B, et al. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 1995; 113: 1514–1517
   PubMed Web of Science ®Google Scholar
• Toris C B, Tafoya M E, Camras C B, et al. Effects of apraclonidine on aqueous humor dynamics in human eyes. Oph-tlialmology 1995; 102: 456–461
   PubMed Web of Science ®Google Scholar
• Toris C B, Camras C B, Yablonski M E, et al. Acute versus chronic effects of brimonidine on aqueous humor dynamics in human eyes. Invest Ophthalmol Vis Sci 1997; 38: S243, ARVO Ab-stracts
   Web of Science ®Google Scholar
• Maus T L, Nau C, Brubaker R F. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents. Arch Ophthalmol 1999; 117: 586–591
   PubMedGoogle Scholar
• Wang R F, Camras C B, Podos S M, et al. The role of prostaglandins in the para-aminoclonidine-induced reduction of intraocular pressure. Trans Am Ophthalmol Soc 1989; 87: 94–104
   PubMedGoogle Scholar
• Lee P Y, Serle J B, Podos S M, et al. Time course of the effect of UK 14304–18 (brimonidine tartrate) on rabbit uveoscleral outflow. Invest Ophthalmol Vis Sci 1992; 33: 1118, ARVO Abstracts
   Web of Science ®Google Scholar
• Bito L Z. Species differences in the response of the eye to irritation and trauma: A hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research. Exp Eye Res 1984; 39: 807–829
   PubMed Web of Science ®Google Scholar
• Poyer J F, Gabelt B T, Kaufman P L. The effect of topical PGF2α on uveoscleral outflow and outflow facility in the rabbit eye. Exp Eye Res 1992; 54: 277–283
   PubMed Web of Science ®Google Scholar
• Lin P J, Hung P T, Wang T H, Ho T C. Effect of topical indomethacin and apraclonidine hydrochloride on intraocular pressure in normal subjects. Invest Ophthalmol Vis Sci 1991; 32(988(suppl))
   Google Scholar
• McCannel C, Koskela T, Brubaker R F. Topical flurbiprofen pretreatment does not block apraclonidine's effect on aqueous flow in humans. Arch Ophthalmol 1991; 109: 810–811
   PubMedGoogle Scholar
• Siegel M J, Camras C B, Lustgarten J S, et al. Effect of flurbiprofen on the reduction of intraocular pressure after administration of 1% aproclonidine in patients with glaucoma (letter to editor). Arch. Ophthalmol 1992; 110: 598–599
   PubMedGoogle Scholar
• Sulewski M, Robin A L, Cummings H L, et al. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol. Arch Ophthalmol 1991; 109: 807–809
   PubMedGoogle Scholar
• Toris C B, Tafoya M E, Camras C B, et al. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology 1995; 102: 456–461
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Gabelt B. α2-Adrenergic agonist effects on aqueous humor dynamics. J Glaucoma 1995; 4(suppl 1)S8–S14
   Google Scholar
• Ritch R, Shields M B, Krupin T. Chronic open-angle glaucoma: Treatment overview. The Glaucomas, 2nd edition, R Ritch, M B Shields, T Krupin. Mosby Year-Book, Inc, St. Louis, MO 1996; 1507–1519
   Google Scholar
• Camras C B, Friedman A H, Rodrigues M M, et al. Multiple dosing of prostaglandin F2α or epinephrine on cynomolgus monkey eyes. III. Histopathology. Invest Ophthalmol Vis Sci 1988; 29: 1428–1436
   PubMed Web of Science ®Google Scholar
• Johnson D H. Cytochalasin D increases outflow facility in the human eye in perfusion organ culture. Invest Ophthalmol Vis Sci 1996; 37: S894, ARVO Abstracts
   Web of Science ®Google Scholar
• Tian B, Gabelt B T, Hubbard W C, et al. Effects of protein kinase inhibitors on trabecular and total outflow facility in monkeys. Invest Ophthalmol Vis Sci 1997; 38: S812, ARVO Abstracts
   Web of Science ®Google Scholar
• Peterson J A, Tian B, Kiland J A, et al. Latrunculin (LAT-A) & staurosporin, but not swinholide (SWIN)-A, increase outflow facility in the monkey. Invest Ophthalmol Vis Sci 1996; 37: S825, ARVO Abstract
   Web of Science ®Google Scholar
• Peterson J A, Tian B, Geiger B, et al. In cynomolgus monkeys latrunculin (LAT)-A, LAT-B increase outflow facility, LAT-A decreases intraocular pressure and initially increases aqueous humor formation. Invest Ophthalmol Vis Sci 1997; 38: S243, ARVO Abstracts
   Web of Science ®Google Scholar
• Smith W L. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989; 259: 315–324
   PubMed Web of Science ®Google Scholar
• Ryder M I, Weinreb R N, Alvarado J, et al. The cytoskele-ton of the cultured human trabecular cell. Invest Ophthalmol Vis Sci 1988; 29: 251–260
   PubMed Web of Science ®Google Scholar
• Theriot J A. Regulation of the actin cytoskeleton in living cells. Cell Biol 1994; 5: 193–199
   Google Scholar
• Gips S J. Growth factor receptors, phospholipases, phos-pholipid kinases, and actin reorganization. Cell Biol 1994; 5: 201–208
   Google Scholar
• Liu X, Brandt C R, Gabelt B T, et al. Herpes simplex virus mediated gene transfer to primate ocular tissues. Exp Eye Res 1999, in press
   Web of Science ®Google Scholar
• Borrás T, Tamm E, Zigler J S, Jr. Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest Ophthalmol Vis Sci 1996; 37: 1282–1293
   PubMed Web of Science ®Google Scholar
• Borrás T, Masumoto Y, Epstein D L, et al. Gene transfer to the human trabecular meshwork by anterior segment perfusion. Invest Ophthalmol Vis Sci 1998; 39: 1503–1507
   PubMed Web of Science ®Google Scholar
• Kaufman P L, Jia W W-G, Tan J, et al. A perspective of gene therapy in the glaucomas. Surv Ophthalmol 1999; 43: S91–S97
   Web of Science ®Google Scholar
• Skinner L L, Borrás T, Epstein D L. Effect of replication deficient adenovirus vectors on outflow facility of excised pig eyes. Invest Ophthalmol Vis Sci 1997; 38: S565, ARVO Ab-stracts
   Web of Science ®Google Scholar
• Borrás T, Rowlette L LS, Epstein D L. Adenovirus vector concentration affects the outflow facility of human perfused organ cultures. Invest Ophthalmol Vis Sci 1998; 39: S235, ARVO Ab-stracts
   Google Scholar
• Kaufman P L, Gabelt B T, Cynader M. Introductory comments on neuroprotection. Surv Ophthalmol 1999, in press
   Web of Science ®Google Scholar
• Yang N S. Gene transfer into mammalian somatic cells in vivo. Crit Rev Biotech 1992; 12: 335–356
   PubMed Web of Science ®Google Scholar